2024 American Society of Clinical Oncology Annual Meeting
Find key news and updates for oncology nurses from the 2024 American Society of Clinical Oncology Annual Meeting, held May 31-June 4, 2024, in Chicago.
Narjust Florez, MD, FASCO, discusses key considerations for oncology nurses caring for these patients.
The trial is the first to evaluate the combination of an ADC and a TKI in metastatic urothelial carcinoma.
Learn about a pilot study of a survivorship program that is currently enrolling men with advanced GU cancers.
The study showed that a certain starting dose of the ADC maximized the likelihood of response to treatment.
A new study evaluated how social determinants of health can affect the risk of death in patients with cancer.
EV-302/KEYNOTE-A39 investigators say these results support the combination as a new standard of care for certain patients.
Learn about the TRANSMET trial and several important nursing considerations.
An exploratory analysis of the MOMENTUM trial evaluated how the JAK inhibitor impacted OS and LFS in these patients.
The CheckMate 9DW clinical trial results support the combination as a potential new first-line standard of care.
Learn how a personalized 12-week exercise program can enhance quality of life outcomes in survivors of breast cancer.
A new study shows why it's critical to prioritize clear communication and patient participation in treatment planning.
More than 20% of patients in the study had 10 or more drug prescriptions, indicating a need for careful management.
Nearly all patients in the study had steroid-dependent chronic GVHD, and nearly half had severe chronic GHVD.
A continuing education program helped nurses function collaboratively as part of a multidisciplinary team.
The risk of hospitalization was associated with the number of drugs in a patient's myeloma treatment regimen.
Oncology nurses play a crucial role in the management and care of melanoma, from initial diagnosis through treatment.
Martha Raymond, MA, highlights the patient advocacy networking and learning opportunities available at the conference.
Researchers evaluated the treatment in a large cohort of patients from the GUARDIANS consortium.
Kate O’Connell, RGN, BSc, of Cork University Hospital, shares her experience attending and presenting research.
A new study highlights the effectiveness of a nurse navigation program for patients undergoing treatment for these cancers.
Gretchen McNally, PhD, ANP-BC, AOCNP, discusses what she's most excited about at the annual meeting.
Research suggests that patients are asked to make transplant decisions based on variable information.
The radiotherapy interruption rate was significantly lower in patients receiving the multidisciplinary intervention.
Advertisement
Advertisement
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.